Search results
California Public Employees Retirement System Sells 38,011 Shares of Apellis Pharmaceuticals, Inc....
ETF DAILY NEWS· 6 hours agoCalifornia Public Employees Retirement System reduced its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 20.7% in the fourth quarter, according to ...
Prospects for Crohn's Relief Brighten With New Advancements
WebMD· 22 hours agoMore than 1 million Americans live with Crohn’s, a chronic and sometimes crippling inflammatory...
Luxa Biotechnology Awarded $4 Million CIRM Grant to Support Clinical Trial of Adult RPESC-RPE-4W...
Benzinga· 2 days agoLuxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI) in Rensselaer, New ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 55 minutes agoOrchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced that Bobby Gaspar, M.D., ...
Texas Company's Mission to Cure Macular Degeneration Blindness
Digital Journal· 3 days agoWins Prestigious Gold Stevie(R) Award for Innovative Career and Workforce Readiness Solution Important Deadlines for California Pay Data, ACA, and IRS Form 941 Filings Soon ...
Rat Neurons Repair Mouse Brains That Lack a Sense of Smell
Scientific American· 4 days agoChimeras, fictional creatures made up of a combination of body parts from different animals, such as the mythological Minotaur, have captivated thinkers, philosophers and scientists throughout ...
Synchronisation between the central circadian clock and the circadian clocks of tissues preserves...
Newswise· 2 days agoBarcelona, 2 May 2024 - Discovered in the 1970s, circadian clocks are essential for the regulation of biological time in most cells in the human body. Circadian rhythms, which are coordinated ...
Researcher discusses mechanism behind a birth defect affecting brain size
Medical Xpress· 2 days agoSika Zheng, a professor of biomedical sciences in the School of Medicine and the founding director of the Center for RNA Biology and Medicine at the University of California
Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant
Benzinga· 2 days agoAnova to manage delivery of Phase 1/2a study of DB107 at UCSF, USC, UCSD and with Denovo Biopharma DB107 is a proprietary gene therapy platform for the treatment of patients with newly diagnosed high grade
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoReplay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer (TCR-NK) cell therapy ...